Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Spain

Research and Innovation Action · Running

NABIHEAL Antimicrobial Nanostructured Biomaterials for Complex Wound Healing

Coordinator
Consorcio Centro De Investigacion Biomedica En Red M.p., Spain
Runs
1 January 2023 to 31 December 2026
Status
Running
EU funding
€5.0m
Total cost
€5.0m
Partners
15 organisations in 7 countries
Type
Research and Innovation Action
Grant agreement
101092269

What the project is doing

In the project's own words, from its summary on CORDIS.

Complex wounds are a global health problem with significant impact on the health care economy. In developed countries alone, they impact the quality of life of more than 2% of total population. Complex wounds, including chronic wounds or major burns, are highly susceptible to microbial infection and biofilm formation, and difficult to treat. Moreover, silver is a widely used metal in antimicrobial products to treat wound infections.

However, silver-based products are expensive, and show several drawbacks due to costs, as well as environmental and safety concerns. The NABIHEAL project will develop multifunctional biomaterials, from proof-of-concept (TRL 3) to the preclinical regulatory stage (TRL 5), to improve wound management. The resulting biomaterials will enable affordable treatment of wound infections or prevention of complications during all phases of the wound healing process.

In the short and medium term, NABIHEAL will develop at least two innovative multifunctional wound-healing biomaterials, using affordable EU-based manufacturing technologies. In the long term, NABIHEAL could become a game-changing alternative to silver in wound-healing dressings. A consortium comprising 5 SMEs and 9 academic institutions, with expertise in wound healing product development, evaluation and commercialization, nanotechnology, safety, and regulatory affairs, will join forces to address these ambitious objectives.

Topics

Who is involved

OrganisationCityCountryRole
Consorcio Centro De Investigacion Biomedica En Red M.p.MadridSpainCoordinator
Bionanonet Forschungsgesellschaft MbhGrazAustriaParticipant
Charite - Universitaetsmedizin BerlinBerlinGermanyParticipant
Mybiotech GmbHUberherrnGermanyParticipant
Aarhus UniversitetAarhus CDenmarkParticipant
Agencia Estatal Consejo Superior De Investigaciones CientificasMadridSpainThird party
Asphalion SLBarcelonaSpainParticipant
Bioiberica SauPalafollsSpainParticipant
Histocell SLDerio BizkaiaSpainParticipant
Nanomol Technologies SLCerdanyola Del VallesSpainParticipant
Universidad De CantabriaSantanderSpainThird party
Universidad De GranadaGranadaSpainParticipant
Institut Za Medicinska Istrazivanja I Medicinu RadaZagrebCroatiaParticipant
Technion - Israel Institute of TechnologyHaifaIsraelParticipant
Univerza V MariboruMariborSloveniaParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI